<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">BMC Med. Genet</journal-id>
<journal-title-group>
<journal-title>BMC Medical Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1471-2350</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30841869</article-id>
<article-id pub-id-type="pmc">6402113</article-id>
<article-id pub-id-type="publisher-id">776</article-id>
<article-id pub-id-type="doi">10.1186/s12881-019-0776-0</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A novel deletion mutation in <italic>KMT2A</italic> identified in a child with ID/DD and blood eosinophilia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Haixia</given-names>
</name>
<address>
<email>Zhhxia520@163.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiang</surname>
<given-names>Bingwu</given-names>
</name>
<address>
<email>15058302377@163.com</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Hui</given-names>
</name>
<address>
<email>wzchenhui@126.com</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Xiang</given-names>
</name>
<address>
<email>chenxiangnj2005@aliyun.com</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2877-8637</contrib-id>
<name>
<surname>Cai</surname>
<given-names>Tao</given-names>
</name>
<address>
<email>tcai@nih.gov</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0379 7164</institution-id><institution-id institution-id-type="GRID">grid.216417.7</institution-id><institution>Second Xiangya Hospital, </institution><institution>Central South University, </institution></institution-wrap>Changsha, 410002 Hunan China </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1764 2632</institution-id><institution-id institution-id-type="GRID">grid.417384.d</institution-id><institution>Physical Medicine and Rehabilitation Center, </institution><institution>The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, </institution></institution-wrap>Zhejiang, China </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1764 2632</institution-id><institution-id institution-id-type="GRID">grid.417384.d</institution-id><institution>The Second Affiliated Hospital of Wenzhou Medical University, </institution></institution-wrap>Zhejiang, China </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2297 5165</institution-id><institution-id institution-id-type="GRID">grid.94365.3d</institution-id><institution>Experimental Medicine Section, National Institute of Dental and Craniofacial Research, </institution><institution>National Institutes of Health, </institution></institution-wrap>Bethesda, MD 20892 USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>6</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>6</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>20</volume>
<elocation-id>38</elocation-id>
<history>
<date date-type="received">
<day>1</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>2</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">The <italic>KMT2A</italic> gene encoded lysine methyltransferase plays an essential role in regulating gene expression during early development and hematopoiesis. To date, 92 different mutations of <italic>KMT2A</italic> have been curated in the human gene mutation database (HGMD), resulting in Wiedemann-Steiner syndrome (WDSTS) and intellectual disability (ID)/developmental delay (DD).</p>
</sec>
<sec>
<title>Case presentation</title>
<p id="Par2">In this report, we present a de novo heterozygous deletion mutation [c.74delG; p. (Gly26Alafs*2)] in the <italic>KMT2A</italic> gene, which was identified by trio-based whole exome sequencing from a 5.5-year-old boy with ID/DD, stereotypic hand movements and blood eosinophilia. Many deleterious germline mutations of <italic>KMT2A</italic> have been documented to affect development of central nervous system, oral and craniofacial tissues, but not blood eosinophils.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par3">This is the first report of a rare case with ID/DD as well as eosinophilia, resulting from a previously undescribed null mutation of <italic>KMT2A</italic>. Our findings expand the phenotypical spectrum in affected individuals with <italic>KMT2A</italic> mutations, and may shed some insight into the role of KMT2A in eosinophil metabolism.</p>
</sec>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1186/s12881-019-0776-0) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd><italic>KMT2A</italic> mutation</kwd>
<kwd>Intellectual disability</kwd>
<kwd>Eosinophilia</kwd>
<kwd>Whole exome sequencing</kwd>
<kwd>Case report</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004735</institution-id>
<institution>Natural Science Foundation of Hunan Province</institution>
</institution-wrap>
</funding-source>
<award-id>2017JJ3461</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005890</institution-id>
<institution>Ministry of Health of the People's Republic of China</institution>
</institution-wrap>
</funding-source>
<award-id>201302002</award-id>
<principal-award-recipient>
<name>
<surname>Chen</surname>
<given-names>Xiang</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000072</institution-id>
<institution>National Institute of Dental and Craniofacial Research</institution>
</institution-wrap>
</funding-source>
<award-id>Intramural Research</award-id>
<principal-award-recipient>
<name>
<surname>Cai</surname>
<given-names>Tao</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par17">Neurodevelopmental disorders are a wide range of developmental brain dysfunctions, such as intellectual disability (ID), developmental delay (DD), autism spectrum disorder (ASD), epilepsy, and attention deficit hyperactivity disorder (ADHD). It has been estimated approximately 2% of children with ID/DD [<xref ref-type="bibr" rid="CR1">1</xref>]; many of them are resulted from genetical alterations. Recent analysis showed that 42% neurodevelopmental disorders in children are caused by de novo mutations [<xref ref-type="bibr" rid="CR2">2</xref>]. With the development of high-throughput sequencing technology, such as the whole-exome sequencing (WES), thousands of genes have been identified to be associated with neurodevelopmental disorders [<xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR6">6</xref>].</p>
<p id="Par18">Germline mutations in the <italic>KMT2A</italic> gene (OMIM: 159555) were first identified in patients with Wiedemann-Steiner syndrome [<xref ref-type="bibr" rid="CR7">7</xref>], which is characterized by hypertrichosis cubiti associated with short stature, consistent facial features, mild to moderate ID, behavioral difficulties, and hypertrichosis on the back (WDSTS, OMIM: 605130). On the other hand, many different somatic mutations or chromosomal rearrangements involving the <italic>KMT2A</italic> gene have been identified in affected individuals or families with leukemia, myeloid/lymphoid or mixed-lineage (OMIM: 159555).</p>
<p id="Par19">In our previous studies, we utilized trio-based whole-exome sequencing (trio-WES) on hundreds of affected individuals with neurodevelopmental diseases, and identified multiple de novo or inherited genetic mutations in different causal genes, such as <italic>ANK3</italic>, <italic>PLA2G6</italic>, <italic>BCL11A</italic>, and <italic>PAK2</italic> [<xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR11">11</xref>]. In the present study, a de novo deletion mutation in <italic>KMT2A</italic>, which is predicted to be a null allele, is identified in a boy with ID/DD, stereotypic hand movements, and blood eosinophilia.</p>
</sec>
<sec id="Sec2">
<title>Case presentation</title>
<p id="Par20">The proband was from a nonconsanguineous family; his parents were phenotypically normal. He was first referred to the hospital when he was 3.5-year-old (Fig. <xref ref-type="fig" rid="Fig1">1</xref>A<bold>,</bold> left panel) with a language developmental delay, a middle level of intellectual disability (ID), and stereotypic hand movements. He was born at 40 weeks in an uneventful spontaneous delivery. His height, body weight, and head circumference at birth were 50.0 cm, 3450 g, and 33 cm respectively, which implies no significant prenatal growth retardation. There were no feeding difficulties and epilepsy. He was able to hold his head up at around 5 months old, sit unaided at 7 months, and walk at 17 months. He started babbling words like “baba”, “mama” around 6 months. At age of 3.5 years, he could only speak a single word, like “yi”, but not a complete sentence. Also, he could not point at an object. He could not communicate with others, and avoided eye-to-eye contact with others. He made repetitive and purposeless movements, like hand waving, tapping and scratching. According to the standard of growth and development of children (0~7-year-old Chinese boy), his growth in height (90 cm, − 3 SD), weight (12 kg, − 2.5 SD) and head circumference (47.5 cm, − 2 SD) was significantly delayed. His score in the infant-junior middle school students social living ability scale (S-M Scale) was low. Physical examination in neurological system and cranial MRI found no obvious abnormalities. At the age of 5.5 years (Fig. <xref ref-type="fig" rid="Fig1">1</xref>A, right panel), his height was 102 cm (− 3 SD), weight 15 kg (− 2.5 SD), and head circumference 48.5 cm (− 2 SD).<fig id="Fig1"><label>Fig. 1</label><caption><p>Photographs of the affected boy and the pedigree of his family. (<bold>a</bold>) Facial appearance of the child at 3.5 (left panel) and 5.5 (right panel) years old, respectively. (<bold>b</bold>) The filled square represents the affected proband, empty symbols represent unaffected individuals, square represents male; the circle, female</p></caption><graphic id="MO1" xlink:href="12881_2019_776_Fig1_HTML"></graphic></fig></p>
<p id="Par21">First peripheral venous blood analysis on 3.5-year-old showed increased absolute count of eosinophils (1.847 × 10^9/L, compared to normal level &lt; 0.5*10<sup>9</sup>/L) as well as increased eosinophil ratio (17.1%) [<xref ref-type="bibr" rid="CR12">12</xref>]. After eight months, his eosinophils numbers and eosinophil ratio still remained at higher levels (1.112 × 10^9/L and 10.8%, respectively). Furthermore, bone marrow puncture analysis showed granulocyte hyperplasia (Fig. <xref ref-type="fig" rid="Fig2">2</xref>) and increased eosinophils ratio (5.5%). In addition, blood lymphocyte subset analysis showed no alteration. Virus detection was negative. C-reactive protein and erythrocyte sedimentation rate were normal. Allergy testing was negative. Other clinical data, such as EKG, echocardiogram, chest X-ray, and ultrasonography of abdomen, were all normal.<fig id="Fig2"><label>Fig. 2</label><caption><p>Bone marrow aspirate smear analysis shows eosinophilia. Eosinophils are indicated by arrows</p></caption><graphic id="MO2" xlink:href="12881_2019_776_Fig2_HTML"></graphic></fig></p>
<p id="Par22">A trio-based whole exome sequencing (WES) was performed on the affected individual and his parents. After removing low quality readings and adapter or contaminant sequences, 60.8 Mb cleaning readings per person were produced. Further variant analysis was based on Genome Analysis Toolkit (GATK) annotation, which was described in more details in previous studies [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Approximately 91.54% of target sequences were covered for more than 10 times. After relatively common variants (MAF ≥ 0.1%) were removed based upon several commonly used databases (i.e., dbSNP142, ExAC, 1000 Genomes and 2000 Chinese Han Exome Sequence database, ChES). Potential inherited and de novo mutations (DNM) related to brain developmental disorders [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>] and blood cell development were screened using a recently developed program mirTrios [<xref ref-type="bibr" rid="CR15">15</xref>]. Deleterious variants were predicted utilizing several commonly used online programs, such as SIFT (<ext-link ext-link-type="uri" xlink:href="http://sift.jcvi.org">http://sift.jcvi.org</ext-link>), Polyphen2 (<ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>), MutationTaster (<ext-link ext-link-type="uri" xlink:href="http://www.mutationtaster.org">http://www.mutationtaster.org</ext-link>) and PROVEAN (<ext-link ext-link-type="uri" xlink:href="http://provean.jcvi.org/index.php">http://provean.jcvi.org/index.php</ext-link>), etc. Sequence variants were interpreted based on ACM standards and guidelines [<xref ref-type="bibr" rid="CR16">16</xref>].</p>
<p id="Par23">Finally, bioinformatic analysis identified a de novo mutation of c.74delG in exon 1 of the <italic>KMT2A</italic> gene (GenBank acc. no., NM_001197104.1), which was predicted to result in a premature stop-gain mutation p.(Gly26Alafs*2) in the encoded protein (i.e., histone-lysine N-methyltransferase 2A, GenBank acc. no., NP_001184033.1). Since the mutation is located at the beginning of the <italic>N</italic>-terminal region of the gene product, it is assumed to be a null allele, thereby predicting to be a very strong pathogenic mutation.</p>
<p id="Par24">In HGMD database, there are 67 different mutations responsible for Wiedemann-Steiner syndrome (WDSTS), compared to additional 25 mutations for ID/DD (Table <xref ref-type="table" rid="Tab1">1</xref>). Further analysis revealed more nonsense and loss-of-function (LoF) mutations in the affected individuals with WDSTS compared to the ID/DD group, suggesting LoF alleles are implicated in more severe clinical manifestations in WDSTS group. Since the present case mainly showed mild ID and short stature, but not distinctive facial appearance, we compared the genotype of the boy with additional 25 mutations detected in affected individuals with ID/DD in HGMD (Fig. <xref ref-type="fig" rid="Fig3">3</xref>). Approximately 68% of the mutations, including non-sense, indel, and splicing alleles, are predicted to be LoF alleles, while eight of them (32%) are hypomorphic missense alleles. However, none of these previously genotyped cases, to the best of our knowledge, were reported with blood eosinophilia.<table-wrap id="Tab1"><label>Table 1</label><caption><p><italic>Analysis of KMT2A</italic> mutations in Wiedemann-Steiner syndrome vs ID/DD</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th>Wiedemann-Steiner syndrome (%)</th><th>ID/DD (%)</th><th>This study (ID/DD)</th></tr></thead><tbody><tr><td>Missense</td><td>
<bold>14 (20.9%)</bold>
</td><td>
<bold>8 (32)*</bold>
</td><td></td></tr><tr><td>Nonsense</td><td>
<bold>22 (32.8)*</bold>
</td><td>
<bold>5 (20)</bold>
</td><td></td></tr><tr><td>Splicing</td><td>4 (6.0)</td><td>2 (8)</td><td></td></tr><tr><td>Small deletion</td><td>18 (26.9)</td><td>8 (32)</td><td align="char" char=".">1</td></tr><tr><td>Small insertion</td><td>7 (10.4)</td><td>2 (8)</td><td></td></tr><tr><td>Gross deletion</td><td>2 (2.9)</td><td>0 (0)</td><td></td></tr><tr><td>
<bold>Total LoF alleles</bold>
</td><td>
<bold>53 (79.1)*</bold>
</td><td>
<bold>17 (68)</bold>
</td><td align="char" char=".">1</td></tr><tr><td>
<bold>Total mutations</bold>
</td><td>67</td><td>25</td><td align="char" char=".">1</td></tr></tbody></table><table-wrap-foot><p>*, <italic>P</italic> &lt; 0.01</p></table-wrap-foot></table-wrap><fig id="Fig3"><label>Fig. 3</label><caption><p>Locations of ID/DD-associated KMT2A mutations. 22 mutations in affected individuals with ID/DD disorders are mapped. Colored boxes depict specific functional domains of the encoded protein using SMART program (<ext-link ext-link-type="uri" xlink:href="http://smart.embl-heidelberg.de/">http://smart.embl-heidelberg.de/</ext-link>). The mutation in red represents the current case. Four additional mutations with no predicted protein positions are not shown in the diagram</p></caption><graphic id="MO3" xlink:href="12881_2019_776_Fig3_HTML"></graphic></fig></p>
</sec>
<sec id="Sec3">
<title>Discussion and conclusions</title>
<p id="Par25">The <italic>KMT2A</italic> gene-encoded H3K4 methyltransferase contains multiple conserved functional domains, such as DNA-binding AT-hook motifs, a cysteine-rich CXXC domain, and a C-terminal SET domain (Fig. <xref ref-type="fig" rid="Fig3">3</xref>). KMT2A is abundantly expressed in brain, blood and bone marrow and interacts with multiple target genes for transcriptional regulation [<xref ref-type="bibr" rid="CR17">17</xref>], thereby playing an important role in the development of central nervous system and hematopoietic stem cell differentiation [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>].</p>
<p id="Par26">Different from the effect of germline mutations in <italic>KMT2A</italic> on brain development, somatic truncations or fusion mutations in <italic>KMT2A</italic> are frequently found to be associated with lymphoid leukemia and myeloid leukemia [<xref ref-type="bibr" rid="CR20">20</xref>–<xref ref-type="bibr" rid="CR23">23</xref>]. And yet, a germline missense mutation in <italic>KMT2A</italic> also is identified by whole-exome sequencing to segregate with four patients in a family with B-cell lymphoma [<xref ref-type="bibr" rid="CR24">24</xref>], suggesting a role of KMT2A-encoded protein in hematopoietic stem cell development.</p>
<p id="Par27"><italic>KMT2A</italic> (a.k.a., <italic>MLL</italic>) is abundantly expressed in lymphoid-derived T cells and myeloid granulocytes like the eosinophils (BioGPS and Human Protein Atlas). Eosinophils are a kind of white blood cell, which is originated from bone marrow hematopoietic stem cells. Blood eosinophilia (&gt; 0.5*10<sup>9</sup>/L) [<xref ref-type="bibr" rid="CR25">25</xref>] results from overproduction of eosinophils from abnormal myeloid progenitor cells, thereby serving as an early sign of hematological malignancy [<xref ref-type="bibr" rid="CR26">26</xref>]. Persistent eosinophilia may be caused by chromosomal rearrangements and gene mutations [<xref ref-type="bibr" rid="CR27">27</xref>]. Somatic mutations in <italic>KMT2A</italic> in patients with leukemia or myeloid/lymphoid or mixed-lineage (OMIM: 159555) may accompany with hypereosinophilia. Interestingly, macrophages with a striated eosinophilic cytoplasm were frequently noted in <italic>Mll</italic>-<italic>AF4</italic> fusion gene knock-in mice [<xref ref-type="bibr" rid="CR28">28</xref>], an animal model of lymphoid and myeloid deregulation and hematologic malignancy. In addition, mutations in six additional genes are found to be associated with the phenotype “blood eosinophilia” (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1). However, no deleterious mutations in any of these genes are found in the trio-whole-exome analysis of the present case.</p>
<p id="Par28">In summary, we identified a previously undescribed de novo stop-gain mutation in <italic>KMT2A</italic> in a boy with ID/DD as well as persistent blood eosinophilia. Whether the eosinophilia is directly resulted from the <italic>KMT2A</italic> null mutation needs to be validated in further studies, preferably in additional cases with loss-of function mutations in the <italic>KMT2A</italic> gene.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Additional file</title>
<sec id="Sec4">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12881_2019_776_MOESM1_ESM.docx"><label>Additional file 1:</label><caption><p><bold>Table S1.</bold> Human Blood Eosinophilia-associated Mutated Genes (DOCX 26 kb)</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>ADHD</term>
<def>
<p id="Par4">Attention deficit hyperactivity disorder</p>
</def>
</def-item>
<def-item>
<term>AML-M5</term>
<def>
<p id="Par5">Acute monoblastic leukemia</p>
</def>
</def-item>
<def-item>
<term>AMML-M4</term>
<def>
<p id="Par6">Myelomonocytic leukemia</p>
</def>
</def-item>
<def-item>
<term>ASD</term>
<def>
<p id="Par7">Autism spectrum disorder</p>
</def>
</def-item>
<def-item>
<term>DD</term>
<def>
<p id="Par8">Developmental delay</p>
</def>
</def-item>
<def-item>
<term>H3K4</term>
<def>
<p id="Par9">Histone H3 lysine 4</p>
</def>
</def-item>
<def-item>
<term>HGMD</term>
<def>
<p id="Par10">Human gene mutation database</p>
</def>
</def-item>
<def-item>
<term>ID</term>
<def>
<p id="Par11">Intellectual disability</p>
</def>
</def-item>
<def-item>
<term>KMT2A</term>
<def>
<p id="Par12">Lysine methyltransferase 2A</p>
</def>
</def-item>
<def-item>
<term>LOF</term>
<def>
<p id="Par13">Loss of Function</p>
</def>
</def-item>
<def-item>
<term>MLL</term>
<def>
<p id="Par14">Mixed-lineage leukemia</p>
</def>
</def-item>
<def-item>
<term>NDDs</term>
<def>
<p id="Par15">Neurodevelopmental disorders</p>
</def>
</def-item>
<def-item>
<term>WDSTS</term>
<def>
<p id="Par16">Wiedemann-Steiner syndrome</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<title>Acknowledgements</title>
<p>The authors thank the family for supporting and participating in this research.</p>
<sec id="FPar1">
<title>Funding</title>
<p id="Par29">This study was supported by the research funding from the Chinese Ministry of Health Project (No: 201302002 to XC) and Natural Science Foundation of Hunan Province (No: 2017JJ3461 to HXZ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
</sec>
<sec id="FPar2" sec-type="data-availability">
<title>Availability of data and materials</title>
<p id="Par30">The causal mutation data generated in this study are included in this report. The raw sequence data related to this study are available on request from the corresponding author [TC].</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>Recruited and phenotyped the participants: BWX, HC, XC, HXZ, TC. Sequencing data analysis: TC. Wrote the manuscript: HXZ, TC. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar3">
<title>Ethics approval and consent to participate</title>
<p>Informed consent for participation of this study was obtained from the proband’s parents. This research was approved by the ethics committee of Wenzhou Medical University. As a disclaimer, T.C. represented his own perspective in the article, not that of the National Institute of Dental and Craniofacial Research or the National Institutes of Health.</p>
</sec>
<sec id="FPar4">
<title>Consent for publication</title>
<p>Written informed consent for publication of the case and any accompanying images were obtained from the patient’s parents.</p>
</sec>
<sec id="FPar5">
<title>Competing interests</title>
<p>The authors declare that they have no competing interest. As author Tao Cai is a member of the editorial board (Associate Editor) of this journal.</p>
</sec>
<sec id="FPar6">
<title>Publisher’s Note</title>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarlungeanu</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Novarino</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Genomics in neurodevelopmental disorders: an avenue to personalized medicine</article-title>
<source/>Exp Mol Med
          <year>2018</year>
<volume>50</volume>
<issue>8</issue>
<fpage>100</fpage>
<pub-id pub-id-type="pmid">30089840</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Study</surname>
<given-names>DDD</given-names>
</name>
</person-group>
<article-title>Prevalence and architecture of de novo mutations in developmental disorders</article-title>
<source/>Nature
          <year>2017</year>
<volume>542</volume>
<issue>7642</issue>
<fpage>433</fpage>
<lpage>438</lpage>
<pub-id pub-id-type="pmid">28135719</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boivin</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Kakooza</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Warf</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Davidson</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Grigorenko</surname>
<given-names>EL</given-names>
</name>
</person-group>
<article-title>Reducing neurodevelopmental disorders and disability through research and interventions</article-title>
<source/>Nature
          <year>2015</year>
<volume>527</volume>
<issue>7578</issue>
<fpage>S155</fpage>
<lpage>S160</lpage>
<pub-id pub-id-type="pmid">26580321</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Afenjar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Smol</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Piton</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gerard</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Alembik</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bienvenu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Boursier</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Boute</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Colson</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Wiedemann-Steiner syndrome as a major cause of syndromic intellectual disability: a study of 33 French cases</article-title>
<source/>Clin Genet
          <year>2018</year>
<volume>94</volume>
<issue>1</issue>
<fpage>141</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="pmid">29574747</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Min Ko</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chae</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>TJ</given-names>
</name>
</person-group>
<article-title>Wiedemann-Steiner syndrome with 2 novel KMT2A mutations</article-title>
<source/>J Child Neurol
          <year>2017</year>
<volume>32</volume>
<issue>2</issue>
<fpage>237</fpage>
<lpage>242</lpage>
<pub-id pub-id-type="pmid">27777327</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lelieveld</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Reijnders</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Pfundt</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yntema</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Kamsteeg</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>P</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Willemsen</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Kleefstra</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lohner</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability</article-title>
<source/>Nat Neurosci
          <year>2016</year>
<volume>19</volume>
<issue>9</issue>
<fpage>1194</fpage>
<lpage>1196</lpage>
<pub-id pub-id-type="pmid">27479843</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>WD</given-names>
</name>
<name>
<surname>Dafou</surname>
<given-names>D</given-names>
</name>
<name>
<surname>McEntagart</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Woollard</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Elmslie</surname>
<given-names>FV</given-names>
</name>
<name>
<surname>Holder-Espinasse</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Irving</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Saggar</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Smithson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Trembath</surname>
<given-names>RC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in MLL cause Wiedemann-Steiner syndrome</article-title>
<source/>Am J Hum Genet
          <year>2012</year>
<volume>91</volume>
<issue>2</issue>
<fpage>358</fpage>
<lpage>364</lpage>
<pub-id pub-id-type="pmid">22795537</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>PP</given-names>
</name>
</person-group>
<article-title>Identification of novel mutations in the HbF repressor gene BCL11A in patients with autism and intelligence disabilities</article-title>
<source/>Am J Hematol
          <year>2017</year>
<volume>92</volume>
<issue>12</issue>
<fpage>E653</fpage>
<lpage>E656</lpage>
<pub-id pub-id-type="pmid">28891213</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>ZS</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Identification of novel compound mutations in PLA2G6-associated neurodegeneration patient with characteristic MRI imaging</article-title>
<source/>Mol Neurobiol
          <year>2017</year>
<volume>54</volume>
<issue>6</issue>
<fpage>4636</fpage>
<lpage>4643</lpage>
<pub-id pub-id-type="pmid">27395053</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>ZS</given-names>
</name>
</person-group>
<article-title>Mutations of ANK3 identified by exome sequencing are associated with autism susceptibility</article-title>
<source/>Hum Mutat
          <year>2012</year>
<volume>33</volume>
<issue>12</issue>
<fpage>1635</fpage>
<lpage>1638</lpage>
<pub-id pub-id-type="pmid">22865819</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ju</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PAK2 Haploinsufficiency results in synaptic cytoskeleton impairment and autism-related behavior</article-title>
<source/>Cell Rep
          <year>2018</year>
<volume>24</volume>
<issue>8</issue>
<fpage>2029</fpage>
<lpage>2041</lpage>
<pub-id pub-id-type="pmid">30134165</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brito-Babapulle</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>The eosinophilias, including the idiopathic hypereosinophilic syndrome</article-title>
<source/>Br J Haematol
          <year>2003</year>
<volume>121</volume>
<issue>2</issue>
<fpage>203</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="pmid">12694242</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Ran</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database</article-title>
<source/>Mol Psychiatry
          <year>2016</year>
<volume>21</volume>
<issue>2</issue>
<fpage>290</fpage>
<lpage>297</lpage>
<pub-id pub-id-type="pmid">25849321</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Identification of a novel mutation of RUNX2 in a family with supernumerary teeth and craniofacial dysplasia by whole-exome sequencing: a case report and literature review</article-title>
<source/>Medicine (Baltimore)
          <year>2018</year>
<volume>97</volume>
<issue>32</issue>
<fpage>e11328</fpage>
<pub-id pub-id-type="pmid">30095610</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Ran</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>ZS</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>mirTrios: an integrated pipeline for detection of de novo and rare inherited mutations from trios-based next-generation sequencing</article-title>
<source/>J Med Genet
          <year>2015</year>
<volume>52</volume>
<issue>4</issue>
<fpage>275</fpage>
<lpage>281</lpage>
<pub-id pub-id-type="pmid">25596308</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richards</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aziz</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bale</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bick</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gastier-Foster</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Grody</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Hegde</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lyon</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Spector</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>
<source/>Genet Med
          <year>2015</year>
<volume>17</volume>
<issue>5</issue>
<fpage>405</fpage>
<lpage>424</lpage>
<pub-id pub-id-type="pmid">25741868</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lebrun</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Giurgea</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Goldenberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dieux</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Afenjar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ghoumid</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Diebold</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Mietton</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Briand-Suleau</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Billuart</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular and cellular issues of KMT2A variants involved in Wiedemann-Steiner syndrome</article-title>
<source/>Eur J Hum Genet
          <year>2018</year>
<volume>26</volume>
<issue>1</issue>
<fpage>107</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="pmid">29203834</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ronan</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Crabtree</surname>
<given-names>GR</given-names>
</name>
</person-group>
<article-title>From neural development to cognition: unexpected roles for chromatin</article-title>
<source/>Nat Rev Genet
          <year>2013</year>
<volume>14</volume>
<issue>5</issue>
<fpage>347</fpage>
<lpage>359</lpage>
<pub-id pub-id-type="pmid">23568486</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mishra</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Zaffuto</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Artinger</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Org</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mikkola</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Djabali</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ernst</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>The histone methyltransferase activity of MLL1 is dispensable for hematopoiesis and leukemogenesis</article-title>
<source/>Cell Rep
          <year>2014</year>
<volume>7</volume>
<issue>4</issue>
<fpage>1239</fpage>
<lpage>1247</lpage>
<pub-id pub-id-type="pmid">24813891</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ayton</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sneddon</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Rosewell</surname>
<given-names>IR</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Presley</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Subramanian</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Truncation of the Mll gene in exon 5 by gene targeting leads to early preimplantation lethality of homozygous embryos</article-title>
<source/>Genesis
          <year>2001</year>
<volume>30</volume>
<issue>4</issue>
<fpage>201</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="pmid">11536426</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Guest</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Shilatifard</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis</article-title>
<source/>Nat Rev Cancer
          <year>2010</year>
<volume>10</volume>
<issue>10</issue>
<fpage>721</fpage>
<lpage>728</lpage>
<pub-id pub-id-type="pmid">20844554</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Urtishak</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Rappaport</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Sarezky</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Biegel</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Nichols</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Wilmoth</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Stern</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Felix</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Unique familial MLL (KMT2A)-rearranged precursor B-cell infant acute lymphoblastic leukemia in non-twin siblings</article-title>
<source/>Pediatr Blood Cancer
          <year>2016</year>
<volume>63</volume>
<issue>7</issue>
<fpage>1175</fpage>
<lpage>1180</lpage>
<pub-id pub-id-type="pmid">26999444</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peterson</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Baughn</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Pearce</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Benevides Demasi</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Goble</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Greipp</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Ketterling</surname>
<given-names>RP</given-names>
</name>
</person-group>
<article-title>KMT2A (MLL) rearrangements observed in pediatric/young adult T-lymphoblastic leukemia/lymphoma: a 10-year review from a single cytogenetic laboratory</article-title>
<source/>Genes Chromosomes Cancer
          <year>2018</year>
<volume>57</volume>
<issue>11</issue>
<fpage>541</fpage>
<lpage>546</lpage>
<pub-id pub-id-type="pmid">30203571</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saarinen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kaasinen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Karjalainen-Lindsberg</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Vesanen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Aavikko</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Katainen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Taskinen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kytola</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Leppa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hietala</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Primary mediastinal large B-cell lymphoma segregating in a family: exome sequencing identifies MLL as a candidate predisposition gene</article-title>
<source/>Blood
          <year>2013</year>
<volume>121</volume>
<issue>17</issue>
<fpage>3428</fpage>
<lpage>3430</lpage>
<pub-id pub-id-type="pmid">23457195</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gotlib</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management</article-title>
<source/>Am J Hematol
          <year>2017</year>
<volume>92</volume>
<issue>11</issue>
<fpage>1243</fpage>
<lpage>1259</lpage>
<pub-id pub-id-type="pmid">29044676</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andersen</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Siersma</surname>
<given-names>VD</given-names>
</name>
<name>
<surname>Hasselbalch</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Vestergaard</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mesa</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Felding</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Olivarius</surname>
<given-names>ND</given-names>
</name>
<name>
<surname>Bjerrum</surname>
<given-names>OW</given-names>
</name>
</person-group>
<article-title>Association of the blood eosinophil count with hematological malignancies and mortality</article-title>
<source/>Am J Hematol
          <year>2015</year>
<volume>90</volume>
<issue>3</issue>
<fpage>225</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="pmid">25488524</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anastasi</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The myeloproliferative neoplasms including the eosinophilia-related myeloproliferations associated with tyrosine kinase mutations: changes and issues in classification and diagnosis criteria</article-title>
<source/>Semin Diagn Pathol
          <year>2011</year>
<volume>28</volume>
<issue>4</issue>
<fpage>304</fpage>
<lpage>313</lpage>
<pub-id pub-id-type="pmid">22195408</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Hudson</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kirchhof</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kersey</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy</article-title>
<source/>Blood
          <year>2006</year>
<volume>108</volume>
<issue>2</issue>
<fpage>669</fpage>
<lpage>677</lpage>
<pub-id pub-id-type="pmid">16551973</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>